Skip to content

Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA

Intubation in Morbidly Obese: a Comparison of Airtraq and ILMA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02969889
Enrollment
80
Registered
2016-11-21
Start date
2016-06-30
Completion date
2016-11-30
Last updated
2017-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation Complication, Intubation; Difficult or Failed

Keywords

Airtraq, Intubating laryngeal mask airway, BMI>35

Brief summary

bmı \> 35 morbidly obese patients requiring endotracheal intubation enrolled in this trial. Divided into two groups Airtraq and ILMA. their effectiveness is evaluated.

Detailed description

80 patients, 18-65 years of aged ASA I-III, BMI\> 35 patients enrolled in this trial. Divided into two groups ; Airtraq and ILMA . BMI\>35, upper airway tumour , respiratory infection less than ten days, excluded from this study. patients demographic and airway variables were recoded. Patients were premedicated. After standard anesthesia induction, anesthesia was induced with propofol and fentanyl. Rocuronium was used for neuromuscular blockade. The device insertion and intubation times, number of intubation attempts, mucosal damage, need for optimization maneuvers, effects on hemodynamic parameters and postoperative minor complications were recorded.

Interventions

DEVICEAirtraq

video laryngoscope with a channel

DEVICEILMA

Sponsors

Kocaeli University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

18-65 years of age * ASA I-III * BMI\>35

Exclusion criteria

BMI\<35 * patients have airway tumor * patients undergoing head and neck surgery * upper respiratory infection less than 10 days prior the surgery

Design outcomes

Primary

MeasureTime frameDescription
intubation time1 minutehandling of the device till the endotracheal tube entering the glottis

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026